Vistin Pharma ASA announced that at its AGM held on May 19, 2022, the shareholders approved the board of directors propose to get a power of attorney to pay out a dividend to shareholders for up to NOK 0.75 per share for 2021, until December 31, 2022, and is planned to be distributed as a repayment of paid-in capital (share premium).